cor 132 Pill: blue , round, 9mm
The pill with imprint cor 132 (Blue, Round1) has been identified as Amphetamine and Dextroamphetamine 10 mg and is used for ADHD, and Narcolepsy. It belongs to the drug class CNS stimulants and is classified as a Schedule 2 controlled substance.
Images for cor 132
Amphetamine and Dextroamphetamine
- Imprint
- cor 132
- Strength
- 10 mg
- Color
- Blue
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Core Pharmaceuticals Inc
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
corn starch,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 64720-0132 (Discontinued) | CorePharma, LLC |
| 55289-0680 (Discontinued) | PDRX Pharmaceuticals Inc. (repackager) |
See also:
More about amphetamine / dextroamphetamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,183)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: CNS stimulants
- En español
Patient resources
- Amphetamine and dextroamphetamine drug information
- Dextroamphetamine and amphetamine (Advanced Reading)
- Dextroamphetamine and Amphetamine Tablets
- Dextroamphetamine and Amphetamine Extended-Release Capsules (Adderall XR)
- Dextroamphetamine and Amphetamine Extended-Release Capsules (Mydayis)
Other brands
Adderall, Adderall XR, Mydayis
Professional resources
- Amphetamine monograph
- Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate (FDA)
- Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate ER Capsules (FDA)
Other brands
Adderall, Adderall XR, Mydayis
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.